Search | IOVS | ARVO Journals

View

Showing 1 – 15 of 15

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2018

Establishing a Colony of Non-human Primates with Cystoid Macular Edema

Laura Belen; Kortni Violette; Christopher Schillo; Christopher Gallotta; Christian Grant; Leslie Jost; David Hollander; Andy Whitlock

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):391. doi:

ARVO Annual Meeting Abstract July 2018

Delay of oscillatory potentials links animal models to diabetes in the human eye

Zsolt Ablonczy; Cristiana Giancarlo; Christopher Schillo; Kortni Violette; Dennis Guberski; Barak Yahalom; Laura Belen; Claire Gelfman; April Hall; David Hollander; Andy Whitlock

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4445. doi:

ARVO Annual Meeting Abstract July 2018

Preclinical Assessment of the Syk Inhibitor PRT2761 for Allergic Conjunctivitis

Andy Whitlock; Laura Belen; Matt J Chapin; Paul J Gomes; Matt Birrell; Anjali Pandey; David Hollander

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5568. doi:

ARVO Annual Meeting Abstract September 2016

Evaluation of the effects of SkQ1 in Ora’s rabbit anterior chamber paracentesis model

Laura Belen; Kortni Violette; Christopher Schillo; Andy Whitlock; Anton Petrov

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):5414. doi:

ARVO Annual Meeting Abstract June 2015

Evaluation of a Novel PI3-kinase Inhibitor in a Murine Model of Allergic Conjunctivitis: Treatment of Chronic Inflammation in Ocular Surface Disease

Andy Whitlock; Zhenhua Huang; Yanli Wang; Laura Belen; Claire Mazow Gelfman

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):4886. doi:

ARVO Annual Meeting Abstract April 2014

Optimization of an Inflammation-Based Murine Model of Dry Eye

Laura Belen; Kortni Violette; George W Ousler; Andy Whitlock

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3663. doi:

ARVO Annual Meeting Abstract April 2014

The third generation of antihistamines: Assessment of Histamine H1/H4 Receptor Antagonists in a Murine Model of Allergic Conjunctivitis

Matt J Chapin; Laura Belen; Andy Whitlock; Jac Wijkmans; Tiffany van de Meer; Mounir Andaloussi; Rogier A Smits; Iwan de Esch; Rob Leurs

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):2482. doi:

ARVO Annual Meeting Abstract June 2013

An Evaluation of the Effects of the Repeat Conjunctival Allergen Challenge (CAC) Model in Various Strains of Albino Mice

Kortni Violette; Laura Belen; Jennifer Brackett; Andy Whitlock

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):2551. doi:

ARVO Annual Meeting Abstract June 2013

Evaluation of the Effects of Cis-UCA in a Murine Model for Allergic Conjunctivitis

James McLaughlin; Andy Whitlock; Laura Belen; Jennifer Brackett; Burkhard Blank

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):2554. doi:

ARVO Annual Meeting Abstract June 2013

Validation of the Anterior Chamber Paracentesis Model for the Screening of Novel Ophthalmic Anti-Inflammatory Drug

Laura Belen; Kortni Violette; Jennifer Brackett; Andy Whitlock

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):110. doi:

ARVO Annual Meeting Abstract June 2013

The Use of Soluble Muc-16 (CA-125) as a Clinically Relevant Biomarker and Endpoint in a Mouse Model of Dry Eye

Jennifer Brackett; Laura Belen; Kortni Violette; Andy Whitlock

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):4310. doi:

ARVO Annual Meeting Abstract June 2013

Evaluation of a Topical Cis-urocanic acid in a Murine CAE™ Model of Dry Eye Disease

Andy Whitlock; Laura Belen; Jennifer Brackett; Burkhard Blank

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):902. doi:

ARVO Annual Meeting Abstract March 2012

In Vitro Activity of ACH-0139586, a Novel Isothiazoquinolone, Moxifloxacin and Gatifloxacin Against Clinical Isolates, Including Methicillin and Fluoroquinolone Resistant

Aron Shapiro; Laura Belen; Andy Whitlock; Dan Sahm

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):6259. doi:

ARVO Annual Meeting Abstract April 2011

Murine CAETM Model For Efficient Screening Of Novel Therapeutics For Dry Eye Syndrome

Kathryn S. Crawford; Laura J. Belen; Allison Rumore; Peter Gaines; George W. Ousler, III; Mark B. Abelson

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):3781. doi:

ARVO Annual Meeting Abstract April 2011

Effects of Thymosin β4 in a Murine CAETM Model of Experimental Dry Eye

Christian B. Allan; David Crockford; Kathryn S. Crawford; Laura J. Belen

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):3782. doi:

Advertisement